Skip to main content
. Author manuscript; available in PMC: 2024 Apr 1.
Published in final edited form as: Psychoneuroendocrinology. 2023 Jan 13;150:106025. doi: 10.1016/j.psyneuen.2023.106025

Figure 2.

Figure 2.

(A) Voxel-based morphometry (VBM) measures from 111 brain regions were loaded into a principal component analysis. The overall explanatory value of dimensions 1 and 2 was 29.4% and 15.9%, respectively. (B) Both male sex and OXT treatment lead to greater values in dimension 1 (p < 0.029 for both comparisons). Post-hoc analyses revealed OXT-exposed males had significantly greater dimension 1 scores than Control males (* p = 0.017), while OXT-exposed females tended to be greater than Control females (# p = 0.079). (C) There were no effects in dimension 2.